|1.||Sawamura, Tatsuya: 55 articles (09/2015 - 03/2002)|
|2.||Mehta, Jawahar L: 36 articles (09/2015 - 08/2002)|
|3.||Witztum, Joseph L: 31 articles (10/2014 - 09/2002)|
|4.||Matsuura, Eiji: 29 articles (08/2014 - 01/2002)|
|5.||Itabe, Hiroyuki: 28 articles (10/2013 - 01/2002)|
|6.||Tsimikas, Sotirios: 22 articles (10/2014 - 01/2002)|
|7.||Nilsson, Jan: 20 articles (04/2015 - 05/2003)|
|8.||Kume, Noriaki: 19 articles (10/2013 - 05/2002)|
|9.||Lopez, Luis R: 18 articles (01/2014 - 06/2003)|
|10.||Holvoet, Paul: 18 articles (12/2009 - 10/2002)|
01/01/2012 - "These findings show that PAFR has a pivotal role in macrophages response to oxLDL and suggest that pharmacological intervention at the level of PAFR activation might be beneficial in atherosclerosis."
03/01/2009 - "It also increases monocyte resistance to oxidized LDL-induced apoptosis, which may be beneficial in the prevention of atherosclerosis."
07/01/2005 - "The results suggest that the two compounds are effective in inhibiting the progress of atherosclerosis by alleviating oxidation injury or by inhibiting ox-LDL-induced VSMC proliferation, which may be promising mechanisms for treating atherosclerosis."
04/01/2014 - "Here, we sought to determine the protective effects of DHA against TNF-α-induced stimulation of lectin-like oxidized low-density lipoprotein (LDL) receptor-1 (LOX-1) expression, which is associated with atherosclerosis. "
01/01/2014 - "OxLDL was independently associated with 10-year CAD events but not subclinical atherosclerosis in a general population, and improved the reclassification capacity of Framingham-derived CAD risk functions."
|2.||Cardiovascular Diseases (Cardiovascular Disease)
04/01/2008 - "The novel data may help to design adequate therapeutic strategies against oxLDL-induced cardiovascular diseases."
01/01/2009 - "Increased circulating oxLDL concentrations have been related to cardiovascular disease in some studies, although not always independently after adjustment of classical lipid markers. "
08/01/2015 - "These findings reveal a novel pathway for AT1 activation and suggest a new mechanism whereby oxLDL may be promoting risk for cardiovascular disease."
04/01/2015 - "Our results indicate that the induction of Sestrin2 acts as a compensatory response to oxLDL for survival, implying that stimulating expression of Sestrin2 might be an effective pharmacological target for the treatment of lipid-related cardiovascular diseases. "
01/01/2015 - "Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases."
07/01/2015 - "Moreover, other HDL functions, assessed in protection against LDL oxidation, inhibition of oxidized-LDL-induced inflammation, and protection of endothelial cells from oxidized-LDL-induced apoptosis, were all significantly improved by H2 treatment. "
01/01/2013 - "Our data suggest that LXR α plays a pivotal role in TRPV1-activation-conferred protection against oxLDL-induced lipid accumulation and TNF-α-induced inflammation in macrophages."
03/15/2014 - "In this study, we explored the effects and mechanisms of exogenous EETs on the ox-LDL-induced inflammation of pulmonary artery endothelial cells (PAECs), which were cultured from rat pulmonary arteries. "
08/01/2010 - "In the present study, we tried to examine the possible role of OxLDL in periodontal inflammation in vitro. "
12/01/2005 - "Our study showed that plasma OxLDL levels and low-grade systemic inflammation are increased in men with a high visceral adipose tissue accumulation. "
|4.||Atherosclerotic Plaque (Atheroma)
01/01/2007 - "Local overexpression of PON-1 almost completely eliminated the immunohistochemical signals of the lectin-like oxidized LDL receptor-1 (LOX-1), thereby inhibiting macrophage accumulation, intimal thickening (by 63% compared with control), or atherosclerotic plaque formation in the vascular lumen (by 87.5%). "
10/01/2014 - "This study reports a new camelid single-domain antibody fragment (sdAb) targeting the Lectin-like oxidized low-density lipoprotein receptor (LOX-1), a biomarker for the detection and molecular phenotyping of vulnerable atherosclerotic plaques. "
01/01/2013 - "Three-dimensional modeling of oxidized-LDL accumulation and HDL mass transport in a coronary artery: a proof-of-concept study for predicting the region of atherosclerotic plaque development."
12/15/2005 - "Several studies have shown that oxLDL is present in atherosclerotic lesions and that several factors present in active atherosclerotic plaques can oxidatively modify LDL. "
02/11/2000 - "Since OxLDL is taken up by vascular smooth muscle cells (VSMC) in atheroma, we analyzed the inducible expression of LOX-1 in VSMC in the present study. "
11/01/2004 - "The purpose of this study was to investigate the effects of statins on Ox-LDL in patients with hypercholesterolemia. "
01/01/2015 - "The lipid profile revealed hypercholesterolemia in 22% and elevated oxidized low-density lipoprotein levels in 94% of the patients. "
10/01/2014 - "Increased systemic oxidative modification (oxLDL) and nitration is also observed during hypercholesterolemia. "
02/01/2012 - "Our results suggest that the prothrombotic state associated with hypercholesterolemia is caused by oxLDL-mediated induction of TF expression in monocytes via engagement of a TLR4/TLR6 complex."
08/01/2011 - "Maternal immunization with oxidized low-density lipoprotein prior to pregnancy prevents pathogenic in utero programming by gestational hypercholesterolemia, but it is unknown whether gestational hypercholesterolemia and maternal immunization affect similar pathways. "
|1.||oxidized low density lipoprotein
|5.||Scavenger Receptors (Scavenger Receptor)
|8.||Immunoglobulin M (IgM)
|2.||Renal Dialysis (Hemodialysis)